Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Saracchini

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Revue D'Epidemiologie Et De Sante Publique|January 1, 1989
Risk factors for human immunodeficiency virus (HIV) infection among homosexual and bisexual men in a region at low risk for AIDS: the northeastern part of Italy. AIDS and Related Syndromes Study GroupS Franceschi, D Serraino, S Saracchini, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancerS Tumolo, G Toffoli, S Saracchini, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Variability of tumor markers in the follow-up of patients radically resected for breast cancerM Gion, G Cappelli, R Mione, et al.
Tumori|June 30, 1989
Persistent generalized lymphadenopathy syndrome vs "AIDS"--unrelated malignant lymphoma: comparison of presenting clinical and laboratory findings in 88 patients. AIDS and Related Syndromes Study GroupU Tirelli, E Vaccher, V Zagonel, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patientsM Gion, L Peloso, R Mione, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancerR Sorio, I Robieux, E Galligioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Tumor markers in breast cancer follow-up: a potentially useful parameter still awaiting definitive assessment. Forza Operativa Nazionale sul Carcinoma Mammario (FONCaM)M Gion, P Barioli, R Mione, et al.
The International Journal of Biological Markers|July 1, 1994
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancerM Gion, G Cappelli, R Mione, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tractA Veronesi, E Galligioni, G Lo Re, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplificationS Saracchini, L Foltran, F Tuccia, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Revue D'Epidemiologie Et De Sante Publique|January 1, 1989
Risk factors for human immunodeficiency virus (HIV) infection among homosexual and bisexual men in a region at low risk for AIDS: the northeastern part of Italy. AIDS and Related Syndromes Study GroupS Franceschi, D Serraino, S Saracchini, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancerS Tumolo, G Toffoli, S Saracchini, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Variability of tumor markers in the follow-up of patients radically resected for breast cancerM Gion, G Cappelli, R Mione, et al.
Tumori|June 30, 1989
Persistent generalized lymphadenopathy syndrome vs "AIDS"--unrelated malignant lymphoma: comparison of presenting clinical and laboratory findings in 88 patients. AIDS and Related Syndromes Study GroupU Tirelli, E Vaccher, V Zagonel, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patientsM Gion, L Peloso, R Mione, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancerR Sorio, I Robieux, E Galligioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Tumor markers in breast cancer follow-up: a potentially useful parameter still awaiting definitive assessment. Forza Operativa Nazionale sul Carcinoma Mammario (FONCaM)M Gion, P Barioli, R Mione, et al.
The International Journal of Biological Markers|July 1, 1994
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancerM Gion, G Cappelli, R Mione, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tractA Veronesi, E Galligioni, G Lo Re, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplificationS Saracchini, L Foltran, F Tuccia, et al.
Pageof 2